Titan PharmaceuticalsTTNP
13F holders, Q4 2025 (December 31)4holders −14
0new positions
14sold out
$1.67avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, down 14 from Q3 2025. 0 opened new positions and 14 sold out. The largest holders were CoreCap Advisors, LLC ($147), Global Wealth Strategies & Associates ($3) and Caldwell Sutter Capital, Inc. ($2).
- Company
- Titan Pharmaceuticals Inc.
- Filed as
- BLACK TITAN CORP ORD SHS (Q4 2025)
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 14 | $107K |
All 13F filers, Q3 2025 → Q4 2025: 22,271 shares sold, net −22,271 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| CoreCap Advisors, LLC | 0.00% | No change | 88 | $147 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $3 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $2 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.